Kronos Bio (NASDAQ:KRON) reported quarterly losses of $(1.13) per share. This is a 61.43 percent decrease over losses of $(0.70) per share from the same period last year.
InsideEVs Reports Tesla’s 10% Staff Cuts Have Begun, Ex-Employees Confirm On LinkedIn
https://insideevs.com/news/592520/tesla-10percent-staff-cuts-have-begun-ex-employees-confirm-linkedin/